25 March 2021 Ankylosing Spondylitis Biologics Conditions Scleroderma Considering Taltz withdrawal in PsA patients?
18 March 2021 Ankylosing Spondylitis Biologics Cognitive Therapies FDA approves Actemra for scleroderma lung
10 March 2021 Conditions Research Spondyloarthritis Biobank paves future for musculoskeletal research